Transporters are membrane proteins that modulate the absorption, disposition, and clearance of xenobiotics, and they are potentially involved in adverse drug reactions (ADRs). In the liver, which is the major organ for xenobiotic biotransformation, uptake transporters bring substrates into hepatocytes for further processing, whereas efflux transporters eliminate substrates out of the cell. In predicting pharmacokinetic effects, regulation of transporters may determine the availability of substrates to intracellular enzymes and affect the toxicological responses to xenobiotics. During development, profound changes occur in the expression of transporters, and understanding the age effect is crucial in predicting the efficacy and toxicity of therapeutic drugs for the pediatric population. Furthermore, age profoundly alters the gut microbiome, and this may alter certain microbial metabolites and modify the host response. Very little is known regarding the relationship between transporter regulation and gut microbiome during development. Therefore, the goal of this study was to determine the developmental regulation of transporters using germ-free (GF) mice as a model system. Both conventional (CV) and GF wild-type mice were bred under the same housing conditions, and livers were collected at the following seven ages: Day 1, 5, 10, 15, 25, 60, and 120 (n=5 per age per sex). RNA was isolated from the liver and the mRNA expression was determined using RT-qPCR. Significance was determined using a T-Test between age-matched CV and GF by sex. Our data show that expression levels of Abcg5 and Abcg8 are consistently higher in male GF than CV mice. For Abcg5, GF males at days 1, 60 and 120 and for Abcg8, GF males at days 1, 10, and 120 had significantly higher expression levels than CV mice. Our result suggests that liver transporters may in part be regulated in a microbiome- dependent manner.